Annual CAPEX
$2.68 M
+$1.27 M+89.73%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual capital expenditures is $2.68 million, with the most recent change of +$1.27 million (+89.73%) on December 31, 2021.
- During the last 3 years, PHAS annual CAPEX has risen by +$2.56 million (+2151.26%).
Performance
PHAS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
$58.00 K
+$9000.00+18.37%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly capital expenditures is $58.00 thousand, with the most recent change of +$9000.00 (+18.37%) on June 30, 2022.
- Over the past year, PHAS quarterly CAPEX has dropped by -$194.00 thousand (-76.98%).
Performance
PHAS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
$2.40 M
-$194.00 K-7.48%
June 30, 2022
Summary
- As of February 10, 2025, PHAS TTM capital expenditures is $2.40 million, with the most recent change of -$194.00 thousand (-7.48%) on June 30, 2022.
- Over the past year, PHAS TTM CAPEX has increased by +$1.78 million (+288.51%).
Performance
PHAS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
PHAS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +89.7% | -77.0% | +288.5% |
| 3 y3 years | +2151.3% | -83.2% | +150.1% |
| 5 y5 years | - | - | +150.1% |
PHAS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -96.5% | -15.5% | -10.4% | at low |
| 5 y | 5-year | at high | -64.2% | -96.5% | -15.5% | -10.4% | -74.3% |
| alltime | all time | at high | -95.6% | -96.5% | -15.5% | -10.4% | -96.3% |
PhaseBio Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $58.00 K(+18.4%) | $2.40 M(-7.5%) |
| Mar 2022 | - | $49.00 K(-97.0%) | $2.60 M(-3.1%) |
| Dec 2021 | $2.68 M(+89.7%) | $1.66 M(+159.6%) | $2.68 M(+148.5%) |
| Sep 2021 | - | $638.00 K(+153.2%) | $1.08 M(+74.4%) |
| Jun 2021 | - | $252.00 K(+89.5%) | $618.00 K(-30.3%) |
| Mar 2021 | - | $133.00 K(+141.8%) | $887.00 K(-37.2%) |
| Dec 2020 | $1.41 M | $55.00 K(-69.1%) | $1.41 M(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $178.00 K(-65.8%) | $1.49 M(-12.7%) |
| Jun 2020 | - | $521.00 K(-20.8%) | $1.71 M(+11.5%) |
| Mar 2020 | - | $658.00 K(+383.8%) | $1.53 M(+59.8%) |
| Dec 2019 | $960.00 K(+706.7%) | $136.00 K(-65.6%) | $960.00 K(+5.3%) |
| Sep 2019 | - | $395.00 K(+14.5%) | $912.00 K(+76.4%) |
| Jun 2019 | - | $345.00 K(+310.7%) | $517.00 K(+200.6%) |
| Mar 2019 | - | $84.00 K(-4.5%) | $172.00 K(+95.5%) |
| Dec 2018 | $119.00 K | $88.00 K | $88.00 K |
FAQ
- What is PhaseBio Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual CAPEX year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly CAPEX year-on-year change?
- What is PhaseBio Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals TTM CAPEX year-on-year change?
What is PhaseBio Pharmaceuticals annual capital expenditures?
The current annual CAPEX of PHAS is $2.68 M
What is the all time high annual CAPEX for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual capital expenditures is $2.68 M
What is PhaseBio Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, PHAS annual capital expenditures has changed by +$1.27 M (+89.73%)
What is PhaseBio Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of PHAS is $58.00 K
What is the all time high quarterly CAPEX for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly capital expenditures is $1.66 M
What is PhaseBio Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, PHAS quarterly capital expenditures has changed by -$194.00 K (-76.98%)
What is PhaseBio Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of PHAS is $2.40 M
What is the all time high TTM CAPEX for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high TTM capital expenditures is $2.68 M
What is PhaseBio Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, PHAS TTM capital expenditures has changed by +$1.78 M (+288.51%)